Mature T/NK-cell lymphomas (controls excluding all cancers)

Endpoint Browser PheWeb

CD2_TNK_LYMPHOMA_EXALLC

No definition available.

Endpoint definition

↥

FinnGen phenotype data

individuals

Apply sex-specific rule None

Check conditions None

Check pre-conditions, main-only, mode, registry filters

Hospital Discharge: ICD-10 C84

Cause of death: ICD-10 C84

2 out of 7 registries used, show all original rules.

Check minimum number of events None

Include endpoints None

Remove individuals based on genotype QC

363

CD2_TNK_LYMPHOMA_EXALLC

Control definitions

Control exclude C3_CANCER

Extra metadata

Level in the ICD hierarchy 3

First used in FinnGen datafreeze DF4

Parent code in ICD-10 C81-C96

Name in latin Lymphomata T-cellularia peripherica et cutanea

NAME	CD2_TNK_LYMPHOMA_EXALLC
CONTROL_EXCLUDE	C3_CANCER
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	C84
HD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	C84
COD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

No upset plot: script not run.

No upset table: script not run.

Similar endpoints

↥

List of similar endpoints to Mature T/NK-cell lymphomas (controls excluding all cancers) based on the number of shared cases.

Broader endpoints:

Narrower endpoints:

Mature T/NK-cell lymphomas

Show all endpoint correlations

Summary Statistics

↥

Key figures

	All	Female	Male
Number of individuals	363	135	228
Unadjusted prevalence (%)	0.09	0.06	0.13
Mean age at first event (years)	63.42	62.10	64.21

Mortality

Follow-up	Absolute risk	HR [95% CI]	p	N
1998–2019	-	-	-	-
15 years	-	-	-	-
5 years	-	-	-	-
1 year	-	-	-	-

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

↥

Index endpoint: CD2_TNK_LYMPHOMA_EXALLC – Mature T/NK-cell lymphomas (controls excluding all cancers)
GWS hits:

Survival analyses between endpoints

↥

Plot

before Mature T/NK-cell lymphomas (controls excluding all cancers)
after Mature T/NK-cell lymphomas (controls excluding all cancers)

Loading survival analyses plot

Table

Loading survival analyses table

Drugs most likely to be purchased after Mature T/NK-cell lymphomas (controls excluding all cancers)

↥

Endpoint not on priority list, no data to show.

≡ Risteys

R10

R9

R8

R7

R6

R5

R4

R3